The global market for alpha emitters has been estimated at $XX million for the year 2018 and is projected to reach $XX million by 2024 at a CAGR of XX% during the forecast period 2018 to 2024. Alpha emitters are a type of radioactive substances that decay after emitting alpha particles. Alpha emitter radionuclide has been considered to be a new approach to treat many cancer types. Alpha-particles offer specific tumour cell killing actions causing less damage to surrounding healthy tissues than beta-emitters, and this potential has caught market attention.
Global Alpha Emitters Market Share:
Alpha emitter therapy holds a great promise when compared to chemotherapy as targeted alpha therapy allows easy discrimination between the healthy cells and cancer cells. The end-users of this market are usually Hospital, Imaging centres and research laboratories.
Global Alpha Emitters Market Size:
The number of therapeutic procedures recorded in North America, Europe and Asia-Pacific is 298, 22206,
Global Alpha Emitters Market Growth:
The drivers contributing to the growth of the market are increasing incidences of cardiac & cancer ailments, raised awareness about the potential benefits of targeted alpha therapy and increasing availability of radiopharmaceuticals.
Global Alpha Emitters Market Industry Analysis:
Alpha Emitters market can be segmented by Radionuclide Types which include Terbium (Tb-149), Astatine (At-211), Bismuth (Bi-212), Bismuth (Bi-213), Actinium (Ac-225), Radium (Ra-223), Lead (Pb-212) and others. Based on Medical Application, the market is segmented into Endocrine Tumors, Lymphoma, Bone Metastasis, Thyroid, Ovarian Cancer, Pancreatic Cancer, Melanoma, etc.
Global Alpha Emitters Market Outlook:
Shorter life of radiopharmaceuticals need for high capital investment, stringent regulatory framework and reimbursement issues are the primary factors impacting the Alpha Emitters market growth.
Global Alpha Emitters Market Trends:
Nordion, Bruce Power and Cameco work together to provide a reliable supply of Cobalt-60. New Research by Cardinal Health Specialty Solutions Explores Oncologists’ Views on Emerging Therapies.
Global Alpha Emitters Market Research report includes:
Starting from $2700
Starting from $2700
Starting from $2700
Keep up-to-date with our weekly newsletter, Media Pulse.